img img img img

News

News

VC firm Vivo Capital outlays $740m for biotech investment – Pharmaceutical Technology

VC firm Vivo Capital outlays $740m for biotech investment  Pharmaceutical Technology Vivo Capital secures $740M to invest in preclinical- and clinical-stage biotechs  Fierce Biotech Vivo Capital Closes Opportunity Fund  FIN News Vivo Capital closes on $740m for third cycle of evergreen public fund  Venture Capital Journal Healthcare specialist Vivo Capital closes third Opportunity Fund cycle at $740m  Alternatives Watch

India Private Equity Report 2025 – Bain & Company

India Private Equity Report 2025  Bain & Company Stiff competition in PE/VC fund landscape as more players join in  Business Standard India-focused VCs Bring In More Capital for Startups  Deccan Chronicle India PE-VC market grows 9% to $43 billion in 2024: Report  Zee Business India PE-VC rebounds to $43 billion  The Financial Express